The impact of new drugs and the changing role of transplants in multiple myeloma
Improving the outcomes of transplantation with bispecific antibodies
How can standard risk multiple myeloma (MM) patients be cured?
What has changed in AML treatment in the last 30 years?
Multiple myeloma; advances presented at EHA